Database for prostate cancer in Hong Kong
A Comprehensive Assessment of the Physical and Biological Effects of Patients With Prostate Cancer in Hong Kong
This study collects information from prostate cancer patients in Hong Kong to see how the disease is managed and to improve treatment options based on age and stage of the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Shatin) |
| Trial ID | NCT03344835 on ClinicalTrials.gov |
What this trial studies
This observational study collects data on prostate cancer patients in Hong Kong to analyze disease outcomes and management strategies. It focuses on the rising incidence of prostate cancer and the various treatment options available based on patient age and disease stage. The study utilizes existing screening methods such as digital rectal examination and prostate-specific antigen blood tests to gather information on diagnosed patients. By compiling this data, the study aims to enhance understanding of prostate cancer trends and improve patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are men aged 18 and above who have been clinically diagnosed with prostate cancer.
Not a fit: Patients diagnosed with ductal type prostate cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and outcomes for prostate cancer patients in Hong Kong.
How similar studies have performed: Other studies focusing on prostate cancer data collection and management have shown success in improving patient outcomes, making this approach well-supported.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at the age of 18 or above * Patients with clinical diagnosis of prostate cancer Exclusion Criteria: * Patients diagnosed to have ductal type of prostate cancer
Where this trial is running
Shatin
- Prince of Wales Hospital — Shatin, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Chi Fai NG, MD — Chinese University of Hong Kong
- Study coordinator: Chi Fai NG, MD
- Email: ngcf@surgery.cuhk.edu.hk
- Phone: 3505 2625
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.